Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Lapatinib × Clear all

NCT01700010 2013-01-17

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Phase 2 Withdrawn

Urinary Bladder Neoplasms, Neoplasms

NCT00447226 2012-06-12

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Phase 2 Terminated

32 enrolled 10 charts

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Neoplasms, Ovarian Neoplasms